ARTICLE | Clinical News
Sirukumab: Additional Ph III SIRROUND-T data
November 18, 2016 6:21 PM UTC
Additional data from the double-blind, international Phase III SIRROUND-T (CNTO136ARA3003) trial in 878 patients with moderately to severely active RA who were unresponsive or intolerant to anti-tumor...
BCIQ Target Profiles